GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,517 Cr | ₹1,559 Cr | ₹871 Cr | ₹1,075 Cr | ₹671 Cr |
What is the latest Sundry Debtors ratio of GLAND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,517 Cr |
| Mar2024 | ₹1,559 Cr |
| Mar2023 | ₹871 Cr |
| Mar2022 | ₹1,075 Cr |
| Mar2021 | ₹671 Cr |
How is Sundry Debtors of GLAND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,517 Cr | -2.70 | |
| Mar2024 | ₹1,559 Cr | 78.87 | |
| Mar2023 | ₹871 Cr | -18.93 | |
| Mar2022 | ₹1,075 Cr | 60.19 | |
| Mar2021 | ₹671 Cr | - | |
Compare Sundry Debtors of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹40,595.8 Cr | -3.6% | 6.7% | 32.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3.6% |
6.7% |
32.3% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses